• I Love Lund’s third-quarter loss after financial items widened 99% year-over-year to SEK 151,000, with no net sales.
• The nine-month loss after financial items narrowed 98% year-over-year to SEK 73,000.
• During the third quarter, the company invested SEK 1.5 million in life sciences company Aligned Bio.
• CEO Björn Englund said the portfolio largely performed well during the third quarter.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Love Lund I AB published the original content used to generate this news brief via Cision (Ref. ID: 202610230245BITN____UKPR__SV_20261022-BIT-8696-0) on October 23, 2026, and is solely responsible for the information contained therein.